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The rotavirus major inner capsid protein (VP6) has been expressed in Nicotiana benthamiana plants using vectors based
on potato virus X (PVX). VP6 was expressed either as a fusion with the PVX coat protein or from an additional subgenomic
promoter inserted to enable both VP6 and PVX coat protein to be expressed independently. Both approaches yielded VP6,
which retained the ability to form trimers. VP6 expressed from the subgenomic promoter assembled into paracrystalline
sheets and tubes. Expression as a fusion protein yielded PVX rods that presented an external “overcoat” of VP6, but
unexpectedly, some rotavirus protein also assembled into icosahedral viruslike particles (VLPs). The assembly of viral protein
into VLPs suggests that prior display of VP6 on the flexuous PVX rod facilitates the subsequent assembly of VP6 into stable
icosahedral particles. © 2000 Academic Press
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WINTRODUCTION
Expression of protein in plants has been proposed as
a novel way of generating inexpensive subunit vaccines
(Mason and Arntzen, 1995; Johnson et al., 1997). Three
general approaches can be employed. First, transgenic
plants can be engineered to express foreign proteins
through the stable integration of a foreign gene into the
plant chromosome, but protein yields achieved by this
approach are generally low (Mason and Arntzen, 1995).
Second, plant virus vectors can be used to achieve
transient expression of foreign protein. This approach
results in high yields of either fusion protein or free
polypeptide: if a proteolytic cleavage site is included in
the vector (Beachy et al., 1996; Santa Cruz et al., 1996),
he fusion protein can be cleaved intracellularly to yield
ree polypeptides. The third approach is to insert appro-
riate epitopes into polypeptide loops of the coat protein,
hich are not involved in the subunit interactions re-
uired for the self-assembly of virus particles (Johnson et
l., 1997). All three approaches have been shown to yield
rotein able to elicit good immune responses, with pro-
ection demonstrated following subsequent challenge
ith parvovirus (Dalsgaard et al., 1997), FMDV (Carrillo et
l., 1998), rabies (Modelska et al., 1998), and cholera
Arakawa et al., 1998).
Although soluble viral proteins presented with an ap-
1 To whom correspondence and reprint requests should be ad-
ressed at University of Auckland, School of Biological Sciences, Pri-c
ate Bag 92019, Auckland, New Zealand. Fax: (09) 373 7415. E-mail:
.bellamy@auckland.ac.nz.
0042-6822/00 $35.00
Copyright © 2000 by Academic Press
All rights of reproduction in any form reserved.
444ropriate adjuvant may prime an effective immune re-
ponse, there is accumulating evidence that assembly of
table viruslike particles (VLPs) enhances the uptake of
ntigens by the mucosal immune system (reviewed by
abbaj et al., 1997). Viral proteins expressed in the VLP
orm are not only more immunogenic, but also more
eadily purified. Thus when expressing antigens in
lants, there are substantial advantages in utilizing vi-
uses such as Hepatitis B (Mason et al., 1992;Thanavala
t al., 1995) or Norwalk virus (Mason et al., 1996), for
which the coat protein is known to self-assemble into
stable VLPs.
Rotavirus is the major cause of viral gastroenteritis in
children (Kapikian and Chanock, 1996). As is the case for
Norwalk virus and Hepatitis B, rotavirus capsid proteins
can also assemble into VLPs, but this requires coexpres-
sion of both VP2 and VP6 (Labbe´ et al., 1991). Rotavirus
P6/VP2 particles are known to retain their physical
ntegrity during passage through the gut (Crawford et al.,
994). Moreover, it is known that secretory IgA antibod-
es targeted against VP6 can protect mice against infec-
ion and resolve chronic rotavirus infection (Burns et al.,
996). These results suggest that the expression of VP6
r VP2/VP6 in plants might represent a feasible method
or rotavirus vaccine development, provided that VP6 can
e assembled efficiently into the VLP form.
Here we report that rotavirus VP6 can be expressed in
lants using appropriate potato virus X (PVX) vectors to
roduce either free VP6 or a VP6-PVX coat protein fusion.
hen expressed as free protein from a subgenomic PVXoat protein promoter, VP6 assembles into paracrystal-
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445EXPRESSION OF ROTAVIRUS VP6 IN PLANTSline sheets. In contrast, expression of VP6 as a fusion
with PVX coat protein yields flexuous rods containing a
surface overcoat of VP6. Unexpectedly, expression as
the fusion protein also yielded icosahedral viruslike par-
ticles, implying that presentation of VP6 on the flexuous
PVX rod, followed by proteolytic cleavage, promotes its
assembly into VLPs.
RESULTS
VP6 can be expressed in N. benthamiana using PVX
We first inoculated N. benthamiana with RNA tran-
cripts synthesized from pPVX.VP6-CP (Fig. 1A), which
esulted in systemic infection of the plants after 15–20
ays postinoculation. RT-PCR of leaf samples following
ystemic infection showed that the VP6 insert is stable in
he viral genome for at least 7–10 days following the first
FIG. 1. PVX vectors used for VP6 expression. Boxes represent coding
sequences (not to scale). (A) Vector incorporating VP6-PVX coat protein
fusions based on pTXS.GFP-CP (Santa Cruz et al., 1996) with VP6
replacing the green fluorescent protein (GFP) present in the original
construct. Numbers in italics refer to the amino acid chain length (aa)
of murine rotavirus VP6, the FMDV 2A catalytic peptide, and coat
protein (CP), respectively. Closed arrow is the CP subgenomic pro-
moter. (B) Vectors for the expression and targeting of free VP6.
pPVX.GUS has the backbone of pTXS.GFP-CP with the GUS sequences
from pGC3 (Chapman et al., 1992). VP6 expression was achieved by
eplacing GUS with VP6 and the addition to VP6 of either no leader
equence (pPVX.VP6, targeted to the cytoplasm), the N-terminal signal
equence of the tobacco pathogenesis-related protein S gene (PR-S, 25
a) and C-terminal KDEL (pPVX.VP6ER, targeted to the ER), the N-
terminal PR-S signal sequence only (pPVX.VP6ES, targeted to the extra-
ellular space), or N-terminal chloroplast transit peptide sequence from
he Malus domestica small subunit RUBISCO gene (60 aa, pPVX.VP6CH,
argeted to the chloroplast). Transit/retention sequences are in heavy
hading for each construct. *VP6 lacks the N-terminal methionine
esidue. Closed arrow, CP subgenomic promoter. Open arrow, dupli-
ated CP subgenomic promoter. (See text for further details.)vidence of systemic infection (data not shown). Westernnalysis of leaf sap showed that VP6 is translated as a
usion product with the coat protein, producing a protein
f about the expected size (71 kDa), which reacts with
oth anti-rotavirus and anti-PVX coat protein antibodies.
he expected 46-kDa product (VP6.2A), resulting from
elf-cleavage of the 2A catalytic peptide sequence, was
lso detected using anti-rotavirus antibodies (Fig. 2A).
he ratio of free protein (VP6–2A) to fusion protein (VP6–
A-CP), resulting from the autocatalytic cleavage at the
A sequence, varied in different infections between 1:1
nd 1:5.
The level of VP6 expressed in plant tissue by the
VX.VP6-CP fusion transcripts was determined by com-
aring the band intensity of plant-expressed VP6 with
hat of a known concentration of native, baculovirus-
xpressed VP6. Plants inoculated with transcripts de-
ived from the fusion vector pPVX.VP6-CP produced
bout 1 mg of VP6 per gram of systemically infected
tissue. SDS–PAGE analysis under nondenaturing condi-
tions (37°C, 30 min) demonstrated that the cleaved VP6
product forms trimers (Fig. 2A, lane 2).
To achieve expression of free VP6, we utilized
pPVX.VP6 (Fig. 1B), a recombinant PVX vector that was
able to express b-glucuronidase (GUS) under the control
of a duplicated PVX coat protein subgenomic promoter.
Replacing the uidA gene (encoding GUS) with the murine
VP6 gene yielded pPVX.VP6 (Fig. 1B). When transcripts
from this vector were used to inoculate N. benthamiana,
systemic infection was also achieved after 7–12 days
postinoculation. Western analysis confirmed that free
VP6 expressed from this vector bound anti-rotavirus an-
tibodies and that trimers of VP6 were visible by SDS–
PAGE under nondenaturing conditions (Fig. 2A, lane 3).
The yield of VP6 achieved by this approach was much
higher at approximately 50 mg/gm of fresh leaf tissue
see below).
P6 expression is not enhanced by targeting the
rotein to intracellular compartments
In an attempt to boost VP6 yields, the protein was
odified by the addition of N- and C-terminal targeting
equences to target VP6 (Fig. 1B) to the chloroplast
pPVX.VP6CH, small subunit of ribulose bisphosphate car-
boxylase transit peptide sequence), the endoplasmic re-
ticulum (ER) (pPVX.VP6ER; PR-S signal sequence and
DEL), or to the extracellular space (pPVX.VP6ES; PR-S
signal sequence). Nucleotide sequence analysis of
pPVX.VP6ER, pPVX.VP6E, and pPVX.VP6CH showed that
one base change had been introduced during PCR am-
plification. This mutation was located in the PR-S signal
sequence at nucleotide position 11 (A3 T) and resulted
in an amino acid change from Gln to Leu; this change
was not considered significant because it was predicted
to improve signal sequence function.Infection of N. benthamiana plants with RNA tran-
p
d
b
f
p
b
V
t
g
a
g
q
b
p
(
v
i
b
p
s
p
1
t
a
p
d
u
l
(
i
a
t
c
w
r
S
U
(
s
V
p
4
446 O’BRIEN ET AL.scripts derived from pPVX.VP6ER, pPVX.VP6ES, and
PVX.VP6 resulted in visible systemic infection after 12
FIG. 2. VP6 is expressed in N. benthamiana infected with PVX tran-
cripts. (A) Detection of VP6 and the VP6-CP fusion. Samples were pre-
ared by heating aliquots of sap in Laemmli sample buffer for 5 min at
00°C (denaturing conditions) or 30 min at 37°C (nondenaturing condi-
ions). Gel blots were probed with an anti-rotavirus rabbit polyclonal
ntibody (upper panel) or an anti-PVX rabbit polyclonal antibody (lower
anel). The trimeric form of VP6 (stable at 37°C) binds more antibody than
oes the monomer. Native VP6 (control) expressed in Spodoptera cells
sing baculovirus (lanes marked 1); pPVX.VP6-CP (VP6-coat protein fusion,
anes marked 2), pPVX.VP6 (free VP6, lanes marked 3), mock-infected
lanes marked 4), PVX UK3 transcripts (wild type, lanes marked 5). Arrows
ndicate the anticipated locations of VP6, trimeric VP6, PVX coat protein,
nd VP6-PVX coat protein fusion. (B) Proteins from leaves infected with
argeted VP6 constructs. Double lanes represent duplicate plants for each
onstruct. All samples were denatured at 100°C. Blots were first probed
ith anti-rotavirus polyclonal antiserum (upper panels), then stripped and
eprobed with an anti-PVX antiserum (lower panels). VP6 expressed in
podoptera cells using baculovirus (lane 1), mock infected (lane 2), PVX
K3 (wild type, lanes marked 3), pPVX.GUS (lanes marked 4), pPVX.VP6
free VP6, cytoplasm, lanes marked 5), pPVX.VP6CH (chloroplast, lanes
marked 6), pPVX.VP6ER (ER, lanes marked 7), and pPVX.VP6ES (extracellular
pace, lanes marked 8). The predicted Mr of PR-S-VP6-KDEL (lanes 7),
PR-S-VP6 (lanes, 8) and ssuRUBISCO-VP6 (lanes 6) are 49 kDa (425 aa), 48
kDa (421 aa), and 52 kDa (457aa), respectively. The predicted Mr of
P6-KDEL and VP6, the cleavage products derived, respectively, from
PVX.VP6ER and pPVX.VP6ES and pPVX.VP6CH expressed in plants are 45.5,
4.5, and 45 kDa, respectively.CH
ays, with VP6 expression achieved by all three recom-inant viruses (Fig. 2B). Most of the VP6 protein derived
rom pPVX.VP6CH (with the chloroplast transit peptide
sequence), pPVX.VP6ER, and pPVX.VP6ES (both with the
PR-S sequence) had reduced gel mobility compared with
that of native VP6, presumably as a result of incorrect
posttranslational processing. The pPVX.VP6CH protein
samples (Fig. 2B, lane 6) contained two bands that were
consistent with the predicted sizes for VP6 (45 kDa) and
the ssu-RUBISCO transit peptide fused to VP6 (52 kDa),
indicating that a large portion of the protein was probably
not correctly processed. For pPVX.VP6ER (lane 7) and
PVX.VP6ES (lane 8), plant extracts contained a single
and that migrated at a higher molecular weight than
P6, indicating that either none of the PR-S signal pep-
ide fused to VP6 is removed or that the protein is
lycosylated. All modified forms of VP6 yielded protein
ble to trimerize under nondenaturing conditions, sug-
esting that the presence of additional terminal se-
uences did not interfere with protein folding and assem-
ly (data not shown).
Western blot analysis showed that all the infected
lants contained a similar amount of PVX coat protein
Fig. 2B, lower panel), indicating that all the recombinant
iruses produced a similar amount of viral protein in
nfected plants. The amount of VP6 present in N.
enthamiana plants inoculated with transcripts from
PVX.VP6 was the highest, at approximately 50 mg of VP6
per gram of fresh tissue. Whether the addition of signal
sequences achieved the localization desired is unclear,
but none of the engineered transcripts improved yields of
VP6.
The failure to detect increased protein levels resulting
from the targeted expression of VP6 to subcellular com-
partments could be because of differences in mRNA
stability. Levels of PVX genomic RNA in the infected plant
were therefore assessed by Northern analysis. All plants,
regardless of the transcript used for inoculation, con-
tained full-length viral genomic RNA transcripts in similar
amounts, but with minor differences. Genomic PVX RNA,
extracted from plants systemically infected with tran-
scripts from pPVX.VP6, appeared to be slightly more
abundant than any of the other VP6-containing con-
structs (Fig. 3, lane 5). Thus, although all constructs
yielded satisfactory levels of genomic RNA in the in-
fected cell, none achieved yields of VP6 geater than that
achieved by VP6 expression in the cytoplasm.
VP6 expressed in plants forms paracrystalline sheets
and tubes
Since VP6 expressed in plant cells assembles into
trimers, we examined in the electron microscope sap
derived from leaves infected with transcripts from
pPVX.VP6, the infectious viral RNA that provided the
highest yield of the unmodified form of the protein. A
range of tubular and sheet forms of VP6 was observed
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447EXPRESSION OF ROTAVIRUS VP6 IN PLANTSwhich bound to anti-VP6 mouse monoclonal antibody
(Fig. 4A). The array periodicity is also characteristic of
VP6 expressed in insect cells (Estes et al., 1987) or
self-assembled from viral protein (Ready and Sabara,
1987). Extracts of VP6 from infected leaves were then
mixed with VP2 particles purified from Spodoptera cells
xpressing the rotavirus VP2 gene under the control of
he baculovirus polyhedral promoter (Fig. 4B). The VP6 of
lant origin assembled onto the VP2 particles and could
e identified as the protein coating the underlying VP2
caffold when appropriate gold-labeled antibodies were
pplied to the grid. Thus, we conclude that the VP6
rotein expressed in plants is able to assemble into
uthentic icosahedral structures, provided the appropri-
te VP2 scaffold is present. It is also clear that any
osttranslational modifications introduced into VP6 in
he plant have not affected the ability of the protein to
ssemble into VLPs.
xpression of the fusion protein yields both coated
VX rods and VLPs composed of VP6
We next examined by electron microscopy the flexu-
us PVX rods from plants infected with transcripts syn-
hesized from pPVX.VP6-CP. This construct incorporates
he FMDV 2A catalytic peptide sequence located be-
ween the VP6 and the PVX coat protein sequences (Figs
A). Immunoelectron microscopy revealed that the flex-
ous PVX rods were coated with VP6 throughout their
ength (Fig. 5), with the surface display of VP6 clearly
etectable by the immunogold-labeled antibody. As an-
icipated, no VP6 was evident on the wild-type PVX rods
nd the VP6-coated rods were clearly distinguishable
hen extracts containing the recombinant and wild-type
FIG. 3. PVX vectors incorporating modified VP6 genes yield similar
evels of genomic RNA in N. benthamiana leaves. Total RNA extracted
from systemically infected N. benthamiana leaves was separated on a
1% agarose gel by electrophoresis and subjected to Northern analysis.
32P-labeled VP6 gene (upper panel), a 32P-labeled PVX coat protein
gene (middle panel), or a 32P-labeled wheat 26s rRNA gene (lower
panel) were used as probes. The same membrane was used but the
probe was stripped after each exposure. Mock inoculation (lane 1), PVX
UK3 (lane 2), pPVX.GUS (lane 3), pPVX.GFP-CP (lane 4), pPVX.VP6
(cytoplasm, lane 5), pPVX.VP6CH (chloroplast, lane 6), pPVX.VP6ER (ER,
ane 7), pPVX.VP6ES (extracellular space, lane 8). Arrow: 7-kb marker.ods were mixed (Fig. 5, lower two panels). We concludehat the fusion protein assembles to coat the viral RNA in
uch a manner that rotavirus VP6 is accessible on the
urface, as has been described previously for fusions
FIG. 4. Murine VP6 expressed in N. benthamiana using pPVX.VP6
forms paracrystalline arrays and can assemble on a VP2 scaffold. (A)
Paracrystalline arrays and tubes formed from VP6 trimers observed in
10% sap samples. Carbon-coated grids were floated on 10% sap and
stained with 2% uranyl acetate. Decoration with anti-mouse gold-IgM
(5-nm particles, indicated by thin lines) was performed after applying
anti-VP6 monoclonal antibody. (B) Assembly of VP6 as a capsid layer
around VP2 cores. VP2 cores were purified from insect cells infected
with recombinant baculovirus. Cores were mixed with 10% sap from
systemically infected leaves (derived from plants inoculated with
pPVX.VP6 transcripts) and incubated overnight at 4°C and then at 37°C
for 2 h. Specimens were applied to grids coated with anti-rotavirus
polyclonal antibody and stained with 2% uranyl acetate. An assembled
VP2/VP6 particle is indicated in the top panel by an open arrow and a
VP2 core is indicated by a closed arrow). For gold decoration, samples
were applied to antibody-coated grids and then floated on an anti-VP2
(mouse) monoclonal/anti-rotavirus (VP6) polyclonal (rabbit) antibody
mix. Samples were then decorated with a mixture of anti-rabbit IgG
(15-nm particles, indicated by thick lines) 1 anti-mouse IgM (5-nm
particles, indicated by thin lines) and then stained with 2% uranyl
acetate. Scale bar 5 100 nm.
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448 O’BRIEN ET AL.incorporating the green fluorescent protein (Santa Cruz
et al., 1996).
The 2A catalytic peptide sequence separates the PVX
and VP6 protein sequences in the fusion so that free
VP6–2A is released by cleavage and is detectable in
extracts (Fig. 2A, lane 2). We therefore searched for
evidence that this free VP6–2A might assemble into
structures such as the tubes and sheets observed in Fig.
4, but no paracrystalline tubes or sheets were observed.
However, unexpectedly, VLPs were observed (Fig. 6) and
these particles are similar in morphology to those pro-
duced when both VP6 and VP2 are expressed in insect
FIG. 5. VP6 is presented on the surface of PVX rods. Purified
PVX.VP6-CP virus (see text) was harvested from CsCl gradients, diluted,
and applied to carbon-coated grids by flotation. Antibody (as indicated)
was applied to the sample by flotation and finally anti-rabbit gold-
labeled IgG (ZYMED, 15 nm) was added. The grids were then stained
with 2% uranyl acetate. The average number of gold beads per viral rod
was determined for each sample (n 5 20): PVX.VP6-CP 1 anti-rotavirus
antibody 5 25; PVX UK3 1 anti-rotavirus antibody 5 1; PVX.VP6-CP 1
nti-PVX coat protein antibody 5 23; PVX UK3 1 anti-PVX coat protein
ntibody 5 17; PVX.VP6-CP 1 negative serum 5 2; PVX UK3 1 negative
erum 5 ,1. Scale bar 5 100 nm.cells by dual infection of cells with the appropriate re-
,
1combinant baculoviruses (compare upper panels of Fig.
6 with lower panels). Immunogold-labeling revealed that
the particles produced in plants are indeed icosahedral
particles assembled from VP6 protein, thus eliminating
the possibility that contamination with some other icosa-
hedral plant virus had occurred in our experiments. The
VP6 particles were present at a lower concentration than
the recombinant PVX rods with a rod:particle ratio of the
order of 50:1. Given that the ratio of fusion protein to VP6
is approximately 5:1 (Fig. 2A) and the VP6-coated rods
are approximately 500 nm in length (Fig. 5), the number
of icosahedral VP6 shells is about that predicted if most
of the free VP6–2A was, in fact, present in VLP (icosa-
hedral) form. VP6–2A assembled as VLPs would subse-
quently dissociate into trimers when analyzed on SDS–
PAGE under nondenaturing conditions (Fig. 2).
DISCUSSION
The use of plants as bioreactors for the synthesis of
proteins appears to have the potential to make an im-
portant contribution to reducing the cost of vaccine pro-
duction and delivery. Indeed, recombinant plant virus
particles delivered by the oral (Modelska et al., 1998) or
ntranasal route (Brennan et al., 1999; Durrani et al., 1998)
ave been shown to be protective in animal models.
The ability of plant-expressed capsid protein to as-
FIG. 6. Viruslike particles composed of VP6 are assembled in plants.
Plant VLPs were purified along with recombinant PVX (PVX.VP6-CP)
virus preparations. Control samples of VP2/VP6 VLPs were made by
baculovirus expression in insect cells. Both samples were diluted and
applied to carbon-coated grids by flotation. Samples were coated with
anti-rotavirus polyclonal antibody (rabbit) and decorated with anti-
rabbit gold-IgG (15 nm), followed by staining with 2% uranyl acetate.
The average number of gold beads per viruslike particle was deter-
mined for each sample (n 5 20): Plant icosahedral particle 1 anti-
otavirus antibody 5 11; Plant icosahedral particle 1 negative serum 51; VLP (insect cells) 1 anti-rotavirus antibody 5 6; VLP (insect cells)
negative serum 5 ,1. Scale bar 5 100 nm.
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449EXPRESSION OF ROTAVIRUS VP6 IN PLANTSsemble into VLPs has been demonstrated for the Hepa-
titis B surface antigen (Mason et al., 1992) and Norwalk
virus (Mason et al., 1996). The ability of rotavirus VP6 to
self-assemble around a VP2 core is well known from
prior work with baculovirus-expressed protein (Crawford
et al., 1994). Here we have used PVX-based vectors
(Chapman et al., 1992; Santa Cruz et al., 1996) and shown
hat plant-expressed VP6 not only retains the ability to
orm trimers and paracrystalline arrays and tubes, but
lso that it assembles around a VP2 core. All of these
orms of VP6 retain the ability to be recognized by anti-
otavirus polyclonal antibodies, confirming that the plant-
xpressed VP6 is comparable to the VP6 obtained by
ither insect cell expression (Estes et al., 1987; Crawford
t al., 1994) or purification from the virus (Ready and
abara, 1987).
When expressed as a fusion with the PVX coat protein,
P6 is incorporated into PVX rods. VP6 is displayed on
he external surface of the rod and is able to be recog-
ized by anti-rotavirus antibodies. The trimers observed
n the PVX.VP6-CP samples (Fig. 2A, lane 2, 37°C) are
nferred to form from the VP6–2A cleavage product, be-
ause the trimeric molecular weight (;130 kDa) ap-
roaches that predicted from the known molecular
eight (46 kDa) of the monomer. The ability of VP6 with
dded N- and C-terminal sequences to trimerize and
orm paracrystalline arrays has previously been reported
Reddy et al., 1992) and thus the 2A sequence was not
xpected to inhibit trimerization. However, the assembly
f icosahedral rotavirus VLPs was not anticipated, given
hat previous expression methods employed have
ielded paracrystalline tubes and sheets (Estes et al.,
987, Crawford et al., 1994). To our knowledge this is the
irst report of the intracellular self-assembly of VP6 into
cosahedral particles. Ready and Sabara (1987) showed
hat purified VP6 could self-assemble into particles at pH
.0, but these structures reverted to tubes when dialyzed
o pH 6.0. Since cleavage of the 2A catalytic peptide is
otranslational (Ryan et al., 1994; Halpin et al., 1999), it is
easonable to infer that at least some of the material
ssembling into VLPs would have been cleaved to yield
P6 accompanied by the C-terminal catalytic peptide.
owever uncleaved VP6–2A-CP fusion protein would
lso be available for assembly, leading to the possibility
hat the PVX sequences rather than those of the 2A
atalytic peptide could be acting to nucleate assembly of
he VLP.
Expressed proteins can be targeted to specific sub-
ellular organelles using localization sequences (Van
en Broeck et al., 1985; Sijmons et al., 1990; Boevink et
l., 1996; Bosch et al., 1996) and in some instances
igh-level expression has been achieved (McBride et al.,
994). A PVX vector has also been developed for the
argeting of expressed proteins to the ER of plant cells
Boevink et al., 1996). The protein profile of plant sap
nfected with transcripts from pPVX.VP6CH showed anadditional VP6 band with a higher-than-expected molec-
ular weight (Fig. 2B, lane 6). It is proposed that this band
represents VP6, in which the transit peptide has not been
cleaved, as has been found in other studies (Wu et al.,
1993). The cleavage and targeting of proteins has also
been hypothesized to be impaired if the transit peptide is
unable to unfold the protein when crossing membranes
(Eilers and Schatz, 1986), so the stability of VP6 may have
inhibited unfolding and therefore targeting. Preliminary
evidence did show that some VP6 was targeted to the
chloroplast (data not shown). No evidence of VP6 being
targeted to the ER or extracellular space was obtained.
The higher molecular weights of the VP6 bands from the
sap of plants infected with pPVX.VP6ER and pPVX.VP6ES
transcripts (Fig. 2B, lanes 7 and 8) indicate that the VP6
was not processed and so retained the additional N-
terminal PR-S sequence. Alternatively there is a possi-
bility that passage of VP6 through the plant cell ER
resulted in glycosylation and hence yielded an increased
molecular weight. Glycosylation of VP6 resulting in de-
creased mobility in SDS–PAGE has previously been ob-
served when VP6 passed through the ER of mammalian
cells (Reddy et al., 1992).
The yield of VP6 from constructs targeting VP6 expres-
sion to subcellular organelles was approximately 15-fold
less than that observed for expression using pPVX.VP6
(data not shown). The levels of PVX genomic RNA (Fig. 3)
for these constructs did not show more than a fivefold
difference when normalized to rRNA loadings, and the
levels of PVX coat protein (Fig. 2B) were comparable,
indicating that the differences in expression levels prob-
ably did not result from a reduction in viral replication.
Overall, these results show that, in our hands, maximal
expression of VP6 was achieved in the cytoplasm of
plant cells.
The rotavirus capsid protein VP6 is a potentially useful
antigen because of its inherent stability, ability to self-
assemble into VLPs, and the established protective po-
tential of both rotavirus VLPs (O’Neal et al., 1997) and
anti-VP6 antibodies (Burns et al., 1996). The ability of
plant-expressed VP6 to self-assemble into a VLP struc-
ture would potentially enable this protein to be assem-
bled into a VLP without the need for coexpression of a
VP2 scaffold. Further refinements of vector construction
and cleavage mechanisms would increase the useful-
ness of PVX as a vector for the expression of VP6 and
might improve yields and the efficiency of assembly of
VLPs in the plant cell.
MATERIALS AND METHODS
Construction of PVX vectors encoding VP6
The green fluorescent protein (GFP)-coat protein (CP)
fusion vector pTXS.GFP-CP, which encodes a gfp-2a-cp
gene fusion under the transcriptional control of a sub-
genomic (sg) CP promoter (Santa Cruz et al., 1996), was
((
N
r
450 O’BRIEN ET AL.modified by replacing GFP with VP6. Oligonucleotide
primers (see Table 1) were generated to amplify the
murine EDIM rotavirus VP6 gene from pEWVP6 (Tang et
al., 1997), while incorporating compatible restriction sites
for cloning into pTXS.GFP-CP. The 1.3-kb PCR fragment
was cloned into pGEM-T (Promega) to form pGOBVP6
and sequenced. Insertion of VP6 into the PVX vector
was achieved following digestion of pGOBVP6 and
pTXS.GFP-CP with AflII and NheI and ligation. The result-
ing clone, pTXS-VP6.CP, contained the vp6–2a-cp fusion
gene under the transcriptional control of the duplicated
sg RNA promoter in pTXS.
A PVX vector was constructed to direct the synthesis
of free VP6, rather than VP6-PVX coat protein fusions. As
a first step, a PVX-GUS vector was derived with a single
ATG after the duplicated subgenomic promoter, as fol-
lows. The duplicated promoter of pGC3 (pPVX.GUS)
(Chapman et al., 1992) was combined with the PVX UK3
backbone of pTXS.GFP-CP (pPVX.GFP-CP) (Santa Cruz et
al., 1996). The ApaI/SpeI fragment of pGC3 encompass-
ing the uidA gene was subcloned into pBC KS- to give
pCH213. The poly(A) sequence of pCH213 was then elim-
inated by XhoI/SstII digestion, end-filling the fragment
using Klenow, and then religation to re-create the XhoI
site, to generate pCH171. A novel NheI site was intro-
duced into pCH171 upstream of the uidA gene by in vitro
mutagenesis (primer pCH231, Table 1), resulting in the
clone pCH231. Digestion of pCH231 and pCH153
T
Primers Used to Construct Recombin
Construct/method Localisation/purpose
pCH231 in vitro mutagenesis
MORPH primer cv33
GTCAG
CCGG
NheI
nucle
NheI
pPVX.VP6 Cytoplasm GGGGA
CTCT
pPVX.VP6ER(int) ER (KDEL) GGGTC
pPVX.VP6ER ER (PR-S) ATGAAC
TTTT
CCAA
ATGC
pPVX.VP6CH(int) Chloroplast GGGCA
TACT
pPVX.VP6CH Chloroplast
(RUBISCO transit
peptide)
GGGAT
pTXS.VP6-CP VP6-2A-CP fusion GCACC
CGAT
RT-PCR Virus stability ACCTTG(pTXS.GFP-CP with mGFP5 inserted in the place of GFP) Rwith NheI/XhoI followed by ligation resulted in the clone
pPVX.GUS, in which uidA with a duplicated subgenomic
promoter replaced mGFP5 in pCH153.
Vectors for subcellular targeting of VP6 expression
were generated by replacing GUS in pPVX.GUS with
PCR-derived VP6 fragments. Oligonucleotide primers
were designed to be complementary to the 59 and 39
ends of murine VP6 and to include a 59 SmaI recognition
sequence and 39 ClaI site for cloning (see Table 1). Three
different primer pairs with additional sites or signals
were used in separate PCR reactions on pEWVP6, giving
rise to pPVX.VP6, pPVX.VP6CH(int) and pPVX.VP6ER(int). After
purification, the PCR fragments were blunt-ended (1 unit
T4 DNA polymerase, 2 units Klenow fragment, 2 units T4
polynucleotide kinase, 1 mM dNTP T4 DNA Ligase buffer
[Life Technologies]) at 37°C for 30 min, cut with ClaI and
ligated to SmaI/ClaI digested pPVX.GUS. E. coli STBL2
cells were used for transformation. These steps yielded
a clone for cytoplasmic expression of VP6 (pPVX.VP6)
and intermediate clones for chloroplast targeting
(pPVX.VP6CH(int)) and for endoplasmic reticulum targeting
pPVX.VP6ER(int)). Further modification of pPVX.VP6ER(int)
was performed by generating a DNA fragment through
the annealing of two complementary oligonucleotides
encoding the N. tabacum pathogenesis-related protein S
PR-S) sequence (Table 1), and ligating the fragment to
ruI-digested pPVX.VP6ER(int), forming pPVX.VP6ER. For di-
ecting VP6 expression to the chloroplast, the ssu-
X Vectors and Monitor Their Stability
d primer (59-39) Reverse primer (59-39)
GCTAGCGGATCC
Restriction sites:
c) and BamHI; C:
hanged to create a
TGGATGTGCTGTA CAGTATCGATGTCGACTCACTTT
ACCAGCATGCTTC
GTGCTGTACTCTATCTC CAGTATCGATGTCGACTCAAAG
CTCATCTTTCTTTACCAGCATG
CTTCTAATG
TCAAAAGCTTCCCC
TTCCTTTGTTTTGG
TGTAGCTGTTACTC
GCATGAGTAACAGCTACAAAGT
ATTGGCCAAAACAAAGGAAGGC
ATAAAAGGGGAAGCTTTTGAGG
AAGTTCAT
CATGGATGTGCTG CAGTATCGATGTCGACTCACTTT
ACCAGCATGCTTC
CCTCCATGATTTC GTCAATGCATTGCACTCTTCCTCC
GCATCGATCCGGC
TGCTGTACTCTATC
CGCAAGCTTAAGAAGGTCAAAAT
TCTTTACCAGCATGCTTCTAAT
ATCAAGATTAC TCATGTCCTTCCAAATAGCCTABLE 1
ant PV
Forwar
CACCA
GTGG
(in itali
otide c
site
GCTCA
ATC
GCGAT
TTCC
ATGCC
TACTT
GTATG
CTATC
GGCTT
AGCTA
GGATG
TGTCUBISCO peptide encoding sequence was amplified
w
i
i
o
g
I
t
B
i
w
c
8
N
2
d
p
w
P
i
b
g
s
t
u
w
c
1
s
b
P
b
s
W
b
a
s
p
f
b
(
o
D
t
e
m
w
m
451EXPRESSION OF ROTAVIRUS VP6 IN PLANTSfrom Malus domestica DNA using the primer pair (Table
1). The 180-bp fragment was blunt-ended and mixed with
SmaI-digested pPVX.VP6CH(int); the DNA mix was digested
ith NsiI and then ligated. The resulting clone was des-
gnated pPVX.VP6CH. Both pPVX.VP6 and pPVX.VP6ER
were used to construct pPVX.VP6ES, the vector for target-
ing VP6 expression to the extracellular space. A 2-kb
fragment from ApaI/MluI-digested pPVX.VP6ER, contain-
ng the duplicated promoter, PR-S sequence, and 59 end
f VP6, was gel-purified and ligated to ApaI/MluI-di-
ested pPVX.VP6, to produce pPVX.VP6ES.
n vitro transcription and plant inoculation
SpeI-linearized DNA of PVX constructs was used as a
emplate for in vitro RNA transcription as described by
eck et al. (1990), except that T7 polymerase was used
nstead of SP6 RNA polymerase. The in vitro transcripts
ere mixed with an equal volume of FES buffer (1%
elite, 1% bentonite, 1% tetrasodium pyrophosphate, pH
) immediately prior to inoculation. Three- to 4-week-old
. benthamiana plants, which had been subjected to a
4-h dark period, were dusted with Carborundum pow-
er and manually inoculated with transcripts (2 leaves
er plant, 10 mL per plant). Plants were grown at 22°C
ith 16-h light and 8-h dark.
VX purification
Fresh or stored (280°C) plant tissue, systemically
nfected with recombinant PVX, was homogenized in
uffer (200 mM Na2HPO4, 10 mM EDTA, 0.15% b-mercap-
toethanol, pH 7.2; 10–15% plant fresh weight:buffer vol-
ume) using a blender. The homogenate was filtered
through muslin cloth and then through a Whatman 3-mm
paper disc under vacuum. Filtrate aliquots were clarified
by one passage through 2- to 3-cm-thick celite pads
under vacuum so that the solution was a pale yellow
color. Prior to filtration, the celite was suspended in
buffer (200 mM Na2HPO4, 10 mM EDTA, 1% BSA) over-
night and washed three times in buffer without BSA prior
to use. PVX rods in the clarified filtrate were pelleted by
ultracentrifugation through a 1 mL 10% sucrose cushion
using a Beckman SW28 rotor (27,000 rpm, 3 h, 4°C). The
pellet was suspended in 10 mM Tris–HCl (pH 7.5) and the
virus banded on a preformed CsCl gradient (r 5 1.1–1.4
/cm3 in 10 mM Tris–HCl, pH 7.5) using a Beckman
SW40Ti rotor (36,000 rpm, 1.5 h, 4°C). The broad diffuse
band of virus that formed in the center of the tube was
harvested and CsCl removed by dialysis.
Wild-type PVX UK3 was purified using the method of
Dougherty and Hiebert (1980), with the following modifi-
cation. After the first PEG precipitation (4% PEG, 100 mM
NaCl), the virus pellet was resuspended and concen-
trated by ultracentrifugation over a 35% sucrose cushion
using a Beckman SW28 rotor (25,000 rpm, 3 h, 4°C).SDS–PAGE and Western analysis
The protein profiles of crude 10% sap extracts, purified
PVX, or purified rotavirus VLPs were analyzed by sodium
dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS–PAGE) (Laemmli, 1970) using a 10% resolving and
4% stacking gel, with samples incubated at 100°C for 5
min in Laemmli loading buffer prior to loading. Nonde-
natured VP6 was visualized using SDS–PAGE by incu-
bating the samples at 37°C for 30 min in the presence of
10% b-mercaptoethanol (Ready and Sabara, 1987). The
eparated proteins were transferred onto PROTRAN ni-
rocellulose transfer membrane (Schleicher and Schuell)
sing the Electro-transfer unit (BioRad). Western analysis
as performed using a 1/1500 dilution of rabbit poly-
lonal anti-rotavirus antibody (this laboratory) or a
/10,000 dilution of rabbit anti-PVX CP antibody (R. For-
ter, Hort Research), followed by a 1/2000 dilution of
iotinylated donkey anti-rabbit Ig antibody (Amersham
harmacia Biotech) and a 1/2000 dilution of streptavidin-
iotinylated horseradish peroxidase complex (Amer-
ham) using the protocol recommended for the ECL
estern blotting analysis system (Amersham). Protein
ands were detected using the ECL detection reagents
nd autoradiography performed using Hyperfilm (Amer-
ham).
The amount of VP6 present in two N. benthamiana
lants inoculated with viral transcripts was quantified
ollowing Western analysis. The density of protein
ands from 10% sap (10 mL) and a dilution series of
baculovirus-expressed VP6 (25, 50, 100, 150, and 200
ng) was determined using the Luminescent image
analyzer LAS-100. Data were plotted as a standard
curve and interpolated to determine the amount of VP6
produced in the plants.
RNA extraction and RT-PCR
Total RNA was extracted from plant tissue or purified
virus using TRIzol Reagent (Life Technologies) and the
RNA precipitated with isopropanol. RT-PCR was per-
formed on 1 mg of total RNA using Ready-To-Go Beads
Pharmacia Biotech) and oligo-(dT) primer (Life Technol-
gies) to synthesize the first strand at 37°C for 1 h.
ouble-stranded DNA was synthesized by PCR.
To extract RNA for Northern analysis, frozen plant leaf
issue was ground and resuspended in 500 mL RNA
xtraction buffer (80 mM Tris–HCl, pH 8, 150 mM LiCl, 5
M EDTA, 5% SDS). After extracting the sample twice
ith 500 mL phenol/choroform, the aqueous phase was
ixed with 50 mL 3 M sodium acetate (pH 5) and 500 mL
isopropanol and precipitated at 220°C. After centrifuga-
tion the RNA pellet was washed with 70% ethanol, air
dried, and resuspended in 50 mL DMDC-treated milliQ
water.
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452 O’BRIEN ET AL.Northern blot analysis
RNA samples (5 mg) were separated by electrophore-
sis using a 1% agarose, glyoxyl/DMSO gel (Sambrook et
al., 1989) and the RNA transferred to a nylon membrane
(Boehringer Mannheim) using 0.05 M NaOH for 4–6 h.
After rinsing in 23 SSC (0.3 M NaCl, 0.03 M tri-sodium
citrate, pH 7) the membrane was air-dried overnight and
the nucleic acid fixed by UV cross-linking (1200 mJ) using
the Stratalinker 2400 (Stratagene).
Probes were prepared from DNA fragments isolated
from agarose gels and labeled with [a-32P]dCTP using
he Rediprime II Random Prime Labeling System (Amer-
ham) following the manufacturer’s instructions. Unincor-
orated nucleotides were removed using the Probe-
uant G-50 micro column. A wheat 26s ribosomal RNA
robe was used to estimate RNA loading for each sam-
le.
Blots were prehybridized for 1 h at 65°C in hybridiza-
ion buffer (50 mM PIPES, pH 6.5, 100 mM NaCl, 50 mM
odium phosphate, 1 mM EDTA, 5% SDS) with 200 mL of
10 gL21 denatured salmon sperm. Radioactive DNA
probe was denatured by boiling, chilled on ice, and
added to the membrane in 5 mL of fresh hybridization
buffer. After hybridization at 65°C overnight, the mem-
brane was washed twice in 0.53 SSC/0.1% SDS, sealed
in a plastic bag, and exposed to Kodak X-Omat film using
intensifying screens at 280°C or BAS-MP imaging
lates in a BAS cassette 2040 (FUJI) to detect the radio-
ctive signal.
mmunogold-labeling and electron microscopy
Immunogold-labeling of virus was performed using the
ethod of Kistler and Bullivant (1988). Briefly, virus sam-
les were diluted by half in phosphate-buffered saline
PBS) and adsorbed onto carbon-coated grids by flota-
ion for 1 min. The grids were washed by flotation on
everal drops of PBS. Antibodies (anti-rotavirus rabbit
olyclonal, this laboratory), anti-VP2 mouse monoclonal
3A8/M2), and anti-VP6 mouse monoclonal (IEII) were
ound to the sample by floating the grid on a 1/500
ilution of antibody for 45 min. Following washing, sam-
les were decorated with gold-labeled goat anti-rabbit
gG (15 nm, ZYMED) or gold-labeled goat anti-mouse IgM
5 nm, AuroProbe EM, Amersham) by floating the grid on
1/20 dilution for 45 min. The grids were extensively
ashed and the sample stained using 2% uranyl acetate.
mmunoabsorption of samples onto carbon-coated grids
as performed by first floating a grid on a 1/500 dilution
f appropriate antibody.
Electron microscopy was performed on stained sam-
les (2% uranyl acetate) using a Philips CM12 transmis-
ion electron micropscope and micrographs recorded on
opex electron microscope film (Agfa). Images were
rocessed using a Nikon “Coolscan” micrograph scan-
er.roduction and purification of rotavirus VPLs using
aculovirus
Rotavirus VP6/VP2 viruslike particles (VLPs) were pro-
uced in SF9 insect cells using the method of Crawford
t al. (1994) with some modifications. Briefly, 6 3 108 SF9
cells in 50 mL of SF900 media were infected with recom-
binant baculovirus at a m.o.i. of 10. After a 2-h absorption,
fresh media was added up to 100 mL and the cells
maintained in spinner flasks (Schott) for 5–6 days. The
medium containing VLPs was clarified by low-speed
centrifugation in a Sorvall RT 7 centrifuge (4000 rpm, 10
min, 4°C) and the VLPs pelleted by ultracentrifugation
through a 35% sucrose cushion using a Beckman SW28
rotor (25,000 rpm, 90 min, 4°C).
Single-shelled particles containing VP2 were prepared
as previously described 3 days after infection (Zeng et
al., 1996). The cells were collected by centrifugation
using a Sorvall RT7 centrifuge (4000 rpm, 10 min, 4°C),
washed twice in PBS, and finally suspended in 30 mL of
1% DOC-TED lysis buffer (10 mM Tris–HCl, pH 7.4, 0.1 mM
EDTA, 1% sodium deoxycholate) for 2 min. The cells were
lysed by vortexing for 1 min and sonicated for 3 min
using a Sonifier Converter-L (Branson SonicPower) at
setting 6. VLPS were purified by isopycnic centrifugation
as described earlier and dialyzed against 10 mM Tris–
HCl, pH 7.4, for 2–4 h.
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